Basilea Pharmaceutica AG (BSLN) — Net Asset Momentum
Basilea Pharmaceutica AG (BSLN) recorded a net asset momentum of 58.0% as of December 2025, with net assets of CHF127.94 Million CHF. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See operational self-sufficiency of Basilea Pharmaceutica AG to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Basilea Pharmaceutica AG Net Asset Momentum (2002–2025)
This chart tracks Basilea Pharmaceutica AG's year-over-year net asset growth across 24 annual reporting periods from 2002 to 2025. The most recent momentum reading is +58.0%, with net assets of CHF127.94 Million CHF as of December 2025. Read debt load of Basilea Pharmaceutica AG for a breakdown of total debt and financial obligations.
Annual Net Asset History for Basilea Pharmaceutica AG (2002–2025)
The table below shows the complete annual net asset history for Basilea Pharmaceutica AG from 2002 to 2025, covering 24 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Basilea Pharmaceutica AG stock valuation.
| Year | Net Assets (CHF) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CHF127.94 Million | CHF282.00 Million | CHF154.06 Million | ▲ +58.0% |
| 2024 | CHF81.00 Million | CHF257.76 Million | CHF176.76 Million | ▲ +909.7% |
| 2023 | CHF-10.00 Million | CHF173.29 Million | CHF183.29 Million | ▲ +51.7% |
| 2022 | CHF-20.71 Million | CHF220.85 Million | CHF241.56 Million | ▲ +64.7% |
| 2021 | CHF-58.61 Million | CHF247.27 Million | CHF305.87 Million | ▲ +42.6% |
| 2020 | CHF-102.05 Million | CHF229.79 Million | CHF331.84 Million | ▼ -9.8% |
| 2019 | CHF-92.96 Million | CHF221.47 Million | CHF314.43 Million | ▼ -39.4% |
| 2018 | CHF-66.69 Million | CHF281.75 Million | CHF348.44 Million | ▼ -60.9% |
| 2017 | CHF-41.44 Million | CHF351.17 Million | CHF392.61 Million | ▼ -18.4% |
| 2016 | CHF-35.00 Million | CHF327.76 Million | CHF362.76 Million | ▼ -335.6% |
| 2015 | CHF14.86 Million | CHF398.74 Million | CHF383.88 Million | ▼ -74.4% |
| 2014 | CHF57.93 Million | CHF257.38 Million | CHF199.45 Million | ▼ -18.3% |
| 2013 | CHF70.87 Million | CHF299.76 Million | CHF228.88 Million | ▼ -32.8% |
| 2012 | CHF105.50 Million | CHF375.34 Million | CHF269.84 Million | ▼ -31.2% |
| 2011 | CHF153.27 Million | CHF237.09 Million | CHF83.82 Million | ▼ -27.1% |
| 2010 | CHF210.24 Million | CHF316.54 Million | CHF106.30 Million | ▲ +115.1% |
| 2009 | CHF97.73 Million | CHF206.61 Million | CHF108.88 Million | ▼ -51.1% |
| 2008 | CHF199.74 Million | CHF328.13 Million | CHF128.38 Million | ▼ -40.4% |
| 2007 | CHF335.10 Million | CHF461.45 Million | CHF126.34 Million | ▲ +198.4% |
| 2006 | CHF112.31 Million | CHF203.09 Million | CHF90.78 Million | ▼ -33.1% |
| 2005 | CHF167.87 Million | CHF255.56 Million | CHF87.69 Million | ▼ -19.9% |
| 2004 | CHF209.60 Million | CHF230.78 Million | CHF21.18 Million | ▲ +132.1% |
| 2003 | CHF90.29 Million | CHF107.02 Million | CHF16.73 Million | ▼ -28.0% |
| 2002 | CHF125.38 Million | CHF150.51 Million | CHF25.13 Million | — |